Last updated on February 2018

Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma


Brief description of study

The purpose of this study is to see if an experimental drug, called copanlisib is effective and safe in treating adult participants with cholangiocarcinoma, when used in combination with gemcitabine and cisplatin.

Clinical Study Identifier: NCT02631590

Contact Investigators or Research Sites near you

Start Over

Richard D. Kim, M.D.

H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL United States
  Connect »